DeAngelis LM - Search Results

1

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.

Schaff LR, Lobbous M, Carlow D, Schofield R, Gavrilovic IT, Miller AM, Stone JB, Piotrowski AF, Sener U, Skakodub A, Acosta EP, Ryan KJ, Mellinghoff IK, DeAngelis LM, Nabors LB, Grommes C. Schaff LR, et al. Among authors: deangelis lm. BMC Cancer. 2022 Jan 13;22(1):60. doi: 10.1186/s12885-021-09164-x. BMC Cancer. 2022. PMID: 35027038 Free PMC article. Clinical Trial.

2

Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma.

DeAngelis LM, Wong E, Rosenblum M, Furneaux H. DeAngelis LM, et al. Cancer. 1992 Sep 15;70(6):1607-11. doi: 10.1002/1097-0142(19920915)70:6<1607::aid-cncr2820700628>3.0.co;2-j. Cancer. 1992. PMID: 1325277

3

Combined modality therapy for primary CNS lymphoma.

DeAngelis LM, Yahalom J, Thaler HT, Kher U. DeAngelis LM, et al. J Clin Oncol. 1992 Apr;10(4):635-43. doi: 10.1200/JCO.1992.10.4.635. J Clin Oncol. 1992. PMID: 1548527

4

Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma.

DeAngelis LM, Gnecco C, Taylor L, Warrell RP Jr. DeAngelis LM, et al. Cancer. 1991 May 1;67(9):2241-6. doi: 10.1002/1097-0142(19910501)67:9<2241::aid-cncr2820670905>3.0.co;2-a. Cancer. 1991. PMID: 1707337 Clinical Trial.

5

Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.

DeAngelis LM, Kreis W, Chan K, Dantis E, Akerman S. DeAngelis LM, et al. Cancer Chemother Pharmacol. 1992;29(3):173-7. doi: 10.1007/BF00686248. Cancer Chemother Pharmacol. 1992. PMID: 1733548

6

Primary central nervous system lymphoma as a secondary malignancy.

DeAngelis LM. DeAngelis LM. Cancer. 1991 Mar 1;67(5):1431-5. doi: 10.1002/1097-0142(19910301)67:5<1431::aid-cncr2820670527>3.0.co;2-k. Cancer. 1991. PMID: 1991309

7

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.

DeAngelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G. DeAngelis LM, et al. Neurology. 1990 Jan;40(1):80-6. doi: 10.1212/wnl.40.1.80. Neurology. 1990. PMID: 2296388

8

Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma.

Mencel PJ, DeAngelis LM, Motzer RJ. Mencel PJ, et al. Among authors: deangelis lm. Cancer. 1994 Apr 1;73(7):1892-4. doi: 10.1002/1097-0142(19940401)73:7<1892::aid-cncr2820730720>3.0.co;2-c. Cancer. 1994. PMID: 8137217

9

The clinical spectrum of ocular lymphoma.

Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. Peterson K, et al. Among authors: deangelis lm. Cancer. 1993 Aug 1;72(3):843-9. doi: 10.1002/1097-0142(19930801)72:3<843::aid-cncr2820720333>3.0.co;2-#. Cancer. 1993. PMID: 8334638

10

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.

Freilich RJ, Delattre JY, Monjour A, DeAngelis LM. Freilich RJ, et al. Among authors: deangelis lm. Neurology. 1996 Feb;46(2):435-9. doi: 10.1212/wnl.46.2.435. Neurology. 1996. PMID: 8614508 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page